CAPTRUST Financial Advisors
PDLI

CAPTRUST Financial Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,802
Closed – – 5383
2022
Q1 		$0 Buy
+1,802
New – ﹤0.01% 5371

CAPTRUST Financial Advisors's PDLI Position: Q2 2022 in Review

CAPTRUST Financial Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q2 2022, closing a stake of 1,802 shares.

CAPTRUST Financial Advisors first reported a position in PDLI in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 3 funds tracked by Wall St. Rank hold PDLI as of Q2 2022.

  • CAPTRUST Financial Advisors reported no remaining PDL BioPharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,802 PDL BioPharma, Inc. shares in Q2 2022.
  • CAPTRUST Financial Advisors first reported a position in PDL BioPharma, Inc. in Q1 2022 and held it in 1 quarter.
  • CAPTRUST Financial Advisors's PDL BioPharma, Inc. position peaked at $0 in Q1 2022.
  • 3 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2022, filed 16 Aug 2022.